01 20INCYTE CORP
01 208829013
01 20Blank
01 20Blank
01 202028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3228
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3228
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3227
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-1622
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF P...
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3228
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-1622
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF P...
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-3228
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-1201
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF I...
Patent Expiration Date : 2028-06-12
Patent Expiration Date : 2028-06-12
US Patent Number : 8829013
Drug Substance Claim :
Drug Product Claim :
Application Number : 202192
Patent Use Code : U-1622
Delist Requested :
Patent Use Description : FOR THE TREATMENT OF P...
Patent Expiration Date : 2028-06-12
